RecruitingPhase 2NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Sponsor: Celgene
Missoula, MT · +59 more sites
1 recruiting alzheimer's disease studies with a site in Missoula, MT.
Sponsor: Celgene
Missoula, MT · +59 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.